| Literature DB >> 33809463 |
Min-Kyoung Shin1, Sung Jae Shin2.
Abstract
Mycobacterium avium complex (MAC), a collection of mycobacterial species representing nontuberculous mycobacteria, are characterized as ubiquitous and opportunistic pathogens. The incidence and prevalence of infectious diseases caused by MAC have been emerging globally due to complications in the treatment of MAC-pulmonary disease (PD) in humans and the lack of understating individual differences in genetic traits and pathogenesis of MAC species or subspecies. Despite genetically close one to another, mycobacteria species belonging to the MAC cause diseases to different host range along with a distinct spectrum of disease. In addition, unlike Mycobacterium tuberculosis, the underlying mechanisms for the pathogenesis of MAC infection from environmental sources of infection to their survival strategies within host cells have not been fully elucidated. In this review, we highlight unique genetic and genotypic differences in MAC species and the virulence factors conferring the ability to MAC for the tactics evading innate immune attacks of host cells based on the recent advances in genetic analysis by exemplifying M. avium subsp. hominissuis, a major representative pathogen causing MAC-PD in humans. Further understanding of the genetic link between host and MAC may contribute to enhance host anti-MAC immunity, but also provide novel therapeutic approaches targeting the pangenesis-associated genes of MAC.Entities:
Keywords: M. avium subsp. hominissuis; Mycobacterium avium complex (MAC); epithelial cells; macrophages; virulence-associated genes
Mesh:
Substances:
Year: 2021 PMID: 33809463 PMCID: PMC8000623 DOI: 10.3390/ijms22063011
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Genetic makers and clinical features of the representative strains in MAC (sub)species.
| Species | Strain | Host | Isolate Origin | Genetic Features | Clinical Features | Year of First Description | References | |
|---|---|---|---|---|---|---|---|---|
| IS * | ITS1 ** | |||||||
| I. | ||||||||
| ATCC25291 | Chicken | Denmark | IS | Mav-A | Avian tuberculosis | 1990 | [ | |
| IWGMT49 | Pig | Netherlands | IS | Mav-A | Pulmonary disease | 2002 | [ | |
| ATCC19698 | Cow | USA | IS | Mav-A | Johne’s disease | 1990 | [ | |
| ATCC49884 | Wood pigeon | France | IS | Mav-A | tuberculosis in birds and paratuberculosis in mammals | 1990 | [ | |
| II. Species/subspecies closely related to | ||||||||
|
| ATCC15985 | Human | - | - | Min-A | Pulmonary disease | 1965 | [ |
|
| DSM44623 | Human | Italy | IS | MAC-A | Pulmonary disease | 2004 | [ |
|
| CIP108962 | Human | Colombia | MAC-X | Bacteremia; lymphadenopathy | 2006 | [ | |
|
| DSM45069 | Human | - | - | - | Disseminated osteomyelitis in immunocompromised child | 2008 | [ |
|
| DSM45247 | Human | Netherlands | MAC-Q | A suppurative wound consequent to a dog bite/ cervical lymphadenitis in a child | 2009 | [ | |
|
| CIP109827 | Human | France | - | - | Pulmonary disease | 2009 | [ |
|
| CIP109828 | Human | France | - | - | Pulmonary disease with bilateral bronchiectasis and multiple nodule | 2009 | [ |
|
| CIP109830 | Human | France | - | MAC-K | Pulmonary disease | 2009 | [ |
|
| KCTC 29084 | Human | Korea | - | MIN-A | Pulmonary disease | 2016 | [ |
| DSM45126 | Human | Korea | - | - | Pulmonary disease | 2013 | [ | |
|
| MTCC 9506 | - | India | - | - | Leprosy vaccine candidates | 2008 | [ |
* IS, Insertion Sequence ** ITS1, the internal transcribed spacer 1 region of rRNA genes.
Virulence-associated genes of Mycobacterium avium subsp. hominissuis during the pathogenesis.
| Host Defense | Gene | Description | Strategy of MAH | References | ||
|---|---|---|---|---|---|---|
| Action | Description | Strain | ||||
| Strategy 1. Mucosal epithelial cell adhesion and invasion | ||||||
|
| ag85 | - antigen 85 | attachment | ▪ Binding to fibronectin | MAH ATCC 15769 | [ |
| MAV_3013 | - microaggregate binding protein 1 | invasion/ attachment | ▪ Binding to vimentin | MAH 104 | [ | |
| MAV_4504 | - ABC transporter, ATP-binding protein coordinates | transport | ▪ Translocation of MBP-1 to the bacterial surface | MAH 104 | [ | |
| MAV_1799 | - hypothetical protein | aggregation | ▪ Rapid recruitment of planktonic bacteria | MAH 104 | [ | |
| MAV_0831 | - microaggregate Invasion Protein-1 | invasion/attachment | ▪ Binding to flaminA | MAH 104 | [ | |
|
| - fatty acyl coenzyme A synthase | invasion | ▪ Activation of Cdc42 signaling pathway | MAH 109 | [ | |
|
| - acetyl/propionyl-CoA carboxylase (subunit) | attachment | ▪ Association with GPL biosynthesis | MAH A5 | [ | |
|
| - IMP dehydrogenase | attachment | ▪ Association with GDP-mannose and GPL biosynthesis | MAH A5 | [ | |
|
| - hypothetical membrane protein | attachment | ▪ Association with biosynthesis of aminoadipic acid | MAH A5 | [ | |
| LprB | - leucine-responsive regulatory protein B | cell wall | ▪ Bacterial cell surface protein | MAH 104 | [ | |
| MAVA5_03380 | - FtsK/ SpoIIIE-like DNA translocation protein | transport | ▪ Export of eDNA | MAH A5 | [ | |
| MAVA5_19945 | - carbonic anhydrase | -* | ▪ Export of eDNA in reseponse to bicarbonate | MAH A5 | [ | |
| Strategy 2. Resistance to the phagocytic environment in the immune cells | ||||||
|
| MAV_2043 | - Cu-Zn superoxide dismutase | catalysis | ▪ Protection from oxidative stress | MAH 104 | [ |
| MAV_2839 | - Alkyl hydroperoxide reductase | catalysis | ▪ Protection from oxidative stress | MAH 109 | [ | |
| MAV_4682 | - isocitrate lyase | metabolism | ▪ A key enzyme in glyoxylate shunt | MAH 109 | [ | |
| MAV_2450 | - Polyketide synthase 12 | cell wall | ▪ Association with susceptibility to oxidative products | MAH 104 | [ | |
| MAV_4292 | - Hypothetical protein | -* | ▪ Association with susceptibility to oxidative products (es, nitric oxide) | MAH 104 | [ | |
| MAV_4012 | - Conserved hypothetical protein | -* | ▪ Association with susceptibility to oxidative products | MAH 104 | [ | |
| MAV_4264 | - Hypothetical protein, homology with bacterial regulatory protein TetR domain | -* | ▪ Regulation of the genes that participate in the inhibition of phagosome acidification (ex, MAV_2450, MAV_4292, MAV_4012) | MAH 104 | [ | |
| MAV_4644 | - putative pore-forming protein that has ADP-ribosyltransferase (ADPRT) activity | interfering with host peptide | ▪ Binding to cathepsin Z | MAH 104 | [ | |
|
| MAV_1356 | - calmodulin-like protein | hijacking host protein | ▪ Hijacking to Annexin A1 and S100-A8 | MAH 104 | [ |
| MAV_2928 | - PPE25-MAV | secretion | ▪ Responsible for the Esx-5 region of the Type VII secretion system | MAH 109 | [ | |
| MAV_2941 | - Hypothetical protein, a small protein only present in | hijacking host protein | ▪ Hijacking host trafficking proteins (ex, AP3B1, STX8 and ARCN1) | MAH 104 | [ | |
|
| - Oligopeptide transporter | transport | ▪ Active transport of oligopeptides and small protein (ex, MAV_2941) | MAH 104 | [ | |
| Strategy 3. Resistance to antimicrobial peptide | ||||||
|
|
| - lysyl-transferase-lysyl-tRNA synthetase | lysinylation | ▪ Association with GPL expression | MAH 104 | [ |
| MAV_0216 | - Cutinase superfamily protein | -* | ▪ Resistance to antimicrobial peptide (polymyxin B) | MAH 104 | [ | |
| MAV_3616 | - Long-chain specific acyl-CoA dehydrogenase | -* | ▪ Resistance to antimicrobial peptide (polymyxin B) | MAH 104 | [ | |
| MAV_2450 | - Erythronolide synthase (polyketide synthase), modules 3 and 4 | -* | ▪ Resistance to antimicrobial peptide (polymyxin B) | MAH 104 | [ | |
| Strategy 4. Induction of immune cell death and spreading tactics | ||||||
|
| MAV_2052 | - putative cysteine synthase A protein | induction of cell death | ▪ Induction of cell death through TLR4-dependent ROS production and JNK pathway | MAH 104 | [ |
| MAV_2054 | - 35-kDa major membrane protein 1 | induction of cell death | ▪ Induction of cell death via ROS production and the mitochondrial pathway | MAH 104 | [ | |
| MAVA5_06970 | - a secreted protein | induction of cell death | ▪ Hijacking OPN to hinder the operation of OPN | MAH A5 | [ | |
* This gene is related to the MAH survival strategy for the host defense, but its mechanism has not been confirmed yet.
Figure 1Summary of the strategy of MAH related to mucosal epithelial cell adhesion and invasion. (A) Biofilm formation and eDNA export, which greatly contributes to colonization, persistence and drug resistance, are important survival strategies for MAH. MAH lipoprotein (LprB) and GPL-related genes are involved in biofilm formation, and biofilms are involved in adhesion to mucosal epithelium and non-biological surfaces including PVC pipes, shower heads, and hot tubs. (B) MAH binds to host proteins such as vimentin, and attaches to epithelial cells, and planktonic bacteria are rapidly recruited to form microaggregates. Furthermore, the MAH microaggregates interact with the host protein filamin A through MIP-1 and further manipulate the host cytoskeleton to efficiently invade the host epithelium. (C) MAH can effectively invade mucosal epithelial cells by cytoskeletal rearrangement of host cells by activating the Cdc42 signaling pathway by fadD2, cipA, and other downstream transcriptional regulators. CipA, a domain similar to the PXXP motif of the human piccolo protein; eDNA, extracellular DNA; Fad2, fatty acyl coenzyme A synthase; GPL, glycopeptidolipid; LrpB, leucine-responsive regulatory protein B; MBP-1, microaggregate binding protein 1; MIP-1, microaggregate invasion Protein-1.
Figure 2Summary of survival tactics of MAH within phagocytes from host innate immune effectors MAH infection. Six representative survival strategy of MAH for a series of processes after macrophage phagocytosis was presented. I. Protection from oxidative stress. In the early stages of macrophage infection, MAH expresses genes resistant to oxidative stress. II. Inhibition of phagosome maturation. MAH proteins expressed in the early stages of infection hijack host trafficking proteins, and interfere with their actions, eventually delaying the maturation of the endosome. III. Blocking phagosome-lysosome fusion. MAH proteins regulate phagosome membrane or block phagosome-lysosome fusion. IV. Release of OMV for sustained infection. MAH releases infection maintenance substances such as TDM synthase, SOD, catalase, catalase peroxidase, ahpC, PE / PPE family protein, and eDNA through OMV. V. Induction of immune cell death. MAH-infected macrophages produce TNF, Fas, and TLR-dependent ROS, thereby activating caspase 8 through ASK1/p38 MAPK signals, activating caspase 9 through mitochondrial death signaling, or ER stress-mediated IRE1α-RIDD pathway. And eventually undergo cell death. VI. Infection of bystander macrophage. When cell death is induced, the vacuole membrane loses its integrity, and MAH relies on Brownian motion to meet the macrophage cytoplasmic membrane and transfer to the cytoplasm. Eventually, highly invasive MAH can escape macrophages or bacteria remaining in the apoptic body can be taken up by bystander macrophages. ahpC, alkyl hydroperoxide reductase; AP3B1, subunit beta-1 of adaptor-related protein complex 3; ARCN1, Archain 1; ASK1, Apoptosis signal-regulating kinase 1; CTSZ, cathepsin Z; Cytc, cytochrome c; eDNA, extracellular DNA; IRE1a, Inositol-requiring enzyme-1a; JUK, Jun kinase; OMV, outer membrane vesicle; OPN, osteopontin; PE/PPE family proteins, the protein with the motifs Pro-Glu and Pro-Pro-Glu; PI3K, human phosphatidylinositol 3-kinase; p38-MAPK, p38 mitogen-activated protein kinases; RIDD, regulated Ire1-dependent decay; ROS, reactive oxygen species; SOD, superoxide dismutase; STX8, syntaxin-8; S100-A8, S100 calcium-binding protein A8; TDM, trehalose 6,6′-dimycolate; TNF, tumor necrosis factor.